These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2515656)

  • 1. Quality control of anti-D sera by a panel of donor red cells with weak reacting D antigen and with partial D antigens by the Federation of Netherlands Red Cross Blood Banks.
    van Rhenen DJ; Overbeeke MA
    Vox Sang; 1989; 57(4):273-4. PubMed ID: 2515656
    [No Abstract]   [Full Text] [Related]  

  • 2. Testing efficacy of anti-D sera by a panel of donor red cells with weak reacting D antigen and with partial D antigens.
    van Rhenen DJ; Thijssen PM; Overbeeke MA
    Vox Sang; 1989; 56(4):274-7. PubMed ID: 2503937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing efficacy of anti-D sera by a panel of donor red cells with weak reacting D antigen and with partial D antigens.
    Frame T; van de Kamp G; van Eijk RV
    Vox Sang; 1990; 58(3):232-3. PubMed ID: 2111066
    [No Abstract]   [Full Text] [Related]  

  • 4. Revised guidelines for compatibility testing in hospital blood banks: important changes for quality assurance and procedures.
    Voak D; Waters AH
    Clin Lab Haematol; 1990; 12(2):235-6. PubMed ID: 2119933
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality control-how much is enough?
    Guy LR; Neitzer GM; Klein RE
    Transfusion; 1977; 17(3):183-94. PubMed ID: 301298
    [No Abstract]   [Full Text] [Related]  

  • 6. Sensitivity of routine blood bank methods for the detection of anti-D as determined during proficiency testing.
    Pinkerton PH; Zuber ED; Barr RM; Croucher BE; Quantz MC; Rapson DA; Wood DE; Crockford J; Moore BP
    Am J Clin Pathol; 1984 Sep; 82(3):326-9. PubMed ID: 6431798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quality control for antiglobulin sera (author's transl)].
    Carbonell F; Marty ML; Montoro JA; Soler MA
    Sangre (Barc); 1981; 26(3):283-90. PubMed ID: 6794159
    [No Abstract]   [Full Text] [Related]  

  • 8. The Comprehensive Blood Bank Survey of the College of American Pathologists--1981.
    Walker RH; Kuban DJ; Polesky HF; van der Hoeven LH
    Am J Clin Pathol; 1983 Oct; 80(4 Suppl):585-89. PubMed ID: 6414288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory proficiency in blood banking: the variability of blood bank reagents for blood typing.
    Koepke JA; Thakur K
    Vox Sang; 1972; 22(3):222-8. PubMed ID: 5019391
    [No Abstract]   [Full Text] [Related]  

  • 10. [Revised definition of the concept rhesus-negative blood donor; practical experiences].
    van Rhenen DJ; Overbeeke MA; Dudok de Wit C; Engelfriet CP
    Ned Tijdschr Geneeskd; 1990 May; 134(20):1005-7. PubMed ID: 2112234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do we need to be more concerned about weak D antigens?
    Garratty G
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract]   [Full Text] [Related]  

  • 12. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel?
    Vox Sang; 1982; 43(3):151-68. PubMed ID: 6815895
    [No Abstract]   [Full Text] [Related]  

  • 13. The standardization of the candidate national standard anti-D blood-typing serum with the Groupamatic MG50 system.
    Saito H; Ozaki J; Yasuda J; Kurokawa M; Tomita T; Okubo Y; Tanaka M; Nakagawa S
    Jpn J Med Sci Biol; 1984 Apr; 37(2):83-95. PubMed ID: 6434770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of the immune response of homozygotes for the Rh haplotype --D-- and related haplotypes. Using cells of rare Rh phenotypes.
    Daniels GL
    Rev Fr Transfus Immunohematol; 1982 Apr; 25(2):185-97. PubMed ID: 6808647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The College of American Pathologists comprehensive blood bank survey program, 1973.
    Myhre BA; Koepke JA
    Am J Clin Pathol; 1975 Jun; 63(6 SUPPL):995-1001. PubMed ID: 807100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homing in on D antigen immunogenicity.
    Flegel WA
    Transfusion; 2005 Apr; 45(4):466-8. PubMed ID: 15819664
    [No Abstract]   [Full Text] [Related]  

  • 17. Surface decoration of red blood cells with maleimidophenyl-polyethylene glycol facilitated by thiolation with iminothiolane: an approach to mask A, B, and D antigens to generate universal red blood cells.
    Nacharaju P; Boctor FN; Manjula BN; Acharya SA
    Transfusion; 2005 Mar; 45(3):374-83. PubMed ID: 15752155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythrocyte antibodies in immunoglobulin preparations].
    Ballowitz L; Beck C; Eibs G
    Blut; 1981 May; 42(5):323-4. PubMed ID: 6786396
    [No Abstract]   [Full Text] [Related]  

  • 19. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAP comprehensive blood bank survey--1985.
    Cooper ES; Ryden SE; Schmidt PJ; Walker RH
    Arch Pathol Lab Med; 1987 Oct; 111(10):899-903. PubMed ID: 3115222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.